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Abstract. Many mutagens and carcinogens act via covalent interaction of 
metabolic intermediates with DNA in the target cell. This report groups 
those structural elements which are often found to form the basis for a 
metabolism to such chemically reactive metabolites. ~mpounds which are 
chemically reactive per se and which do not require metabolic activation 
form group 1. Group 2 compri~es of olefins and aromatic hydrocarbons 
where the oxidation via an epoxide can be responsible for the generation of 
reactive species. Aromatic amines, hydrazines, and nitrosamirres form group 
3 requiring an oxidation of a nitrogen atom or of a carbon atom in alpha 
position to a nitrosated amine. Group 4 compounds are halogenated 
hydrocarbons which can either give rise to radicals or can form an ·olefin 
(group 2) upon dehydrohalogenation. Group 5 compounds depend upon 
some preceding enzymatic activity either not available in the target cell or 
acting on positions in the molecule which are not directly involved in the 
subsequent formation of electrophilic atoms. Examples for each group are 
taken from the "List of Chemieals and Irrdustrial Processes Associated with 
Cancer in Humans" as compiled by the International Agency for the 
Research on Cancer, and it is shown that 91% of the organic carcinogens 
would have been detected on the basis of structural elements characteristic 
for group 1-5. As opposed to this very high sensitivity, the specificity ( the 
true negative fraction) of using this approach as a short-term test for 
carcinogenicity is shown to be bad because detoxification pathways have so 
far not been taken into account. These competing processes are so complex, 
however, that either only very extensive knowledge about pharmacokinetics, 
stability, and reactivity will be required or that in vivo systems have to be 
used to predict, on a quantitative basis, the darnage expected on the DNA. 
DNA-binding experiments in vivo are presented with benzene and toluene to 
Abbreviations. CBI, Covalent Binding Index = (!J.mol substance bound per mol DNA 
nucleotides)/(mmol substance administered per kg body weight); HCH, hexachlorocyclohexane 
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demonstrate one possible way for an experimental assessment and it is shown 
that the detoxification reaction at the methyl group available only in toluene 
gives rise to a reduction by at least a factor of forty for the binding to rat liver 
DNA. This quantitative approach available with DNA-binding tests in vivo, 
also allows evaluation as to whether reactive metabolites and their DNA 
binding are always the most important single activities contributing to the 
overall carcinogenicity of a chemical. With the example of the liver-
tumor inducing hexachlorocyclohexane isomers it is shown that situations 
will be found where reactive metabolites are formed and DNA binding in 
vivo is measurable but where this activity cannot be the decisive mode of 
carcinogenic action. It is concluded that the lack of structural elements 
known to become potentially reactive does not guarantee the lack of a 
carcinogenic potential. 
Key words: Structure-activity relationship - Reactive intermediates -
Metabolie activation - DNA Binding - Covalent binding index -
Carcinogens - Benzene - Toluene - Hexachlorocyclohexane - Lindaue 
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It has always been a dream of chemists to predict, on the basis of structure, the 
activity of chemieals in living systems. One is not aware though of any example 
where this approach would not have ended at some point with an exception to a 
rule so carefully established. 
In the last decade, a new wave of optimism swept over the biologically 
interested chemists a:tter the exciting finding that many well-known strong 
carcinogens belanging 'to a number of different chemical classes were shown to 
be metabolized via electrophilic, i.e., chemically reactive intermediates (MillE{r 
1970) and that their covalent binding to DNA seemed to be an important early 
event in the chemical induction of a tumor (Lutz 1979). No wonder that many 
chemists tried to find ways to predict the carcinogenicity on the basis of critical 
structural elements. The most elaborate try came from Cramer et al. (1978) who 
developed a decision tree system where organic chemieals could be placed into 
one of three classes I, II, or III, on the basis of 33 questions. These classes were 
meant to reflect a presumption of low, moderate, or serious toxicity, and the 
authors claimed that so far the procedure had not resulted in any underesti-
mation of toxicity. The analysis reported by Ashby (1978) and by Oesch (1982) 
revealed a much more complicated situation as soon as quantitative assessments 
are attempted. 
The following report will try to answer three questions. How sensitive is a 
short-term test for carcinogenicity based exclusively on critical structural 
elements? How good is the specificity forthistype of test, i.e., how large is the 
fraction of non-carcinogens lacking a critical structural element? If a reactive 
metabolite can be formed, is this activity always the most important for its 
over-all carcinogenic activity? 
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Question 1: How Sensitive is a Test Based 
on Critical Structural Elements? 
W. K. Lutz 
In order to answer the question of sensitivity, there must be some base list of 
chemieals that have been shown to be carcinogenic. In this case, rather 
arbitrarily, the "List of Chemieals and Industrial Processes Associated with 
Cancer in Humans" as compiled by the International Agency for the Research 
on Cancer (IARC 1980) was chosen. It has tobe mentioned that the evidence for 
carcinogenicity is admittedly inadequate for a number of the 54 compounds 
listed there, but the list still seemed appropriate for an evaluation of critical 
structural elements. 
A comparison of the chemical structures revealed five groups where a 
formation of reactive intermediates has tobe envisaged. These will be presented 
in the following sections. 
Group 1: Chemically Reactive per se 
Figure 1 shows a number of structural elements known to the ehernist to be 
electrophilically reactive. The list comprises of the strained three-membered 
rings containing oxygen (a, epoxides), nitrogen (b, aziridines), and sulfur (c, 
epithio derivatives); halogenated a'ikanes ( d and e) where the chloride becomes 
a favourable leaving group in a nucleophilic attack because of neighbouring 
effects by nitrogen (d, mustards) or oxygen (e, ethers): some alkylating and 
Table 1. Group 1 of IARC 1980 list of carcinogens: chemically. reactive per se (13 of 54) 
a) Epoxides 
b) Aziridines 
c) Epithio derivatives 
d) 2-Chloroethyl derivatives 
e) Chloromethyl derivatives 
f) Sulfates, sulfonates 
g) Acid halides 
h) Aldehydes 
i/j) N-Nitroso derivatives 
Numbering according to IARC (1980) 
* Additional carcinogens 
27. Epichlorohydrin 
28. Ethylene oxide 
23. Dieldrin (also group 4) 
52. Triaziquone 
53. Thiotepa 
Epithiobutyronitrile 
12. Chlornaphazine 
16. Chlorambucil 
21. Cyclophosphamide (also group 5) 
37. Melphalan 
38. Mustard gas 
13. Bis( chloromethyl) ether 
26. Dirnethyl sulfate 
25. Dirnethyl carbamoylchloride 
* 
Formaldehyde 
Methylnitrosourea 
Nitrosation products of primary amines 
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acylating agents (f and g); formaldehyde as most reactive representative of the 
class of carbonyl compounds and potential crosslinking agent (h); and two 
derivatives of the important class of N-nitroso derivatives, some of which, like 
ureas and primary amines are known to undergo spontaneous decay to alkylating 
agents. Areaction with a primary amine is depicted in Fig. 1, as one possible 
nucleophile present in protein and nucleie acids. 
Although group 1 chemieals do not require metabolic activation to become 
reactive, this group has been included here and even put first because 13 out of 
the 54 IARC carcinogens belong to this class (Table 1). About half of these are 
cytostatic agents where a reactivity towards DNA is a prerequisite for its 
therapeutic effectiveness. Aldehydesand N-nitroso derivatives have been added 
because of their wide occurrence. 
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Fig. la-j. Structures of chemically reactive carcinogens selected from the IARC (1980) list of 
carcinogens. A primary amine H2NR is shown as the nucleophilic reaction partner. a Epoxides, 
b aziridines, c epithio derivatives, d 2-chloroethyl derivatives (mustards), e chloromethylderivati-
ves, f sulfates, sulfonates, g acid halides ( dimethyl carb amoylchloride), h aldehydes ( formaldehyde), 
ilj N-nitroso-derivatives of a urea and of a primary arnine; i--+ j hydrolysis of the labilized arnide 
bond 
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Group 2: Substituted Olefins 
A large group is formed by those compounds which contain a carbon-carbon 
double bond (Fig. 2), including aromatic systems such as those found in 
polynuclear aromatic hydrocarbons. It is interesting to note that all the 
respective representatives taken from the IARC 1980 list of carcinogens 
(Table 2) have their double bond conjugated ( c, d) or unsymmetrically 
substituted with electrophilic atoms ( a, b). The reactive metabolite derived 
therefrom is an epoxide formed by the monooxygenase system which is discussed 
in more detail in subsequent presentations. Among the standard list of 54, 13 
compounds would have been perceived as potential carcinogens (Table 2). 
Group 3: Oxidation of Nitrogen or of an alpha-Carbon of a Nitrosamine 
Aromatic amines have been responsible for the high incidence of bladder cancer 
in humans exposed to such compounds in the work place. The enzymatic 
activation involves first a N-hydroxylation which is followed by a conjugation 
reaction, potentially leading to a good leaving group aq,d the generation of a 
X 
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Fig. 2a-d. Part structures of 
carcinogens which can form an 
epoxide as reactive metabolite. a, 
b, c Activated olefins, d aromatic 
hydrocarbons; X electrophilic 
Substituent 
TabJe 2. Group 2 of IARC 1980 list of carcinogens: substituted olefins (13 of 54) 
Substitution 
a) With chloride 
b) With oxygen 
c) Unsaturation 
d) In aromatic system 
Numbering according to IARC (1980) 
18. Chlordarre 
47. Polychlorinated biphenyls 
51. Trichloroethy!ene 
54. Vinyl chloride 
2. Aflatoxins 
1. Acrylonitrile 
19. Chloroprene 
24. Diethylstilbestrol 
SO. Styrene 
9. Benzene 
44. Phenobarbitone 
46. Phenytoin 
49. Soots and tars 
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nitronium ion (Fig. 3a). Upon delocalization of electrons, the positive charge 
can move into the aromatic system and the analysis of the reaction products with 
DNA indeed revealed adducts formed via exocyclic nitrogen and ortho-carbon. 
The IARC 1980 list of carcinogens contains as much as seven aromatic amines 
(Table 3). They are probably overrepresented with respect to their importance 
for the general population but they are so numerous in this list because industrial 
exposure to a carcinogen is much more easily detectable by an epidemiological 
analysis. 
Alkyl hydrazines are not only experimental carcinogens but are found as 
drugs and dietary constituents, especially in mushrooms. A postulated 
enzymatic pathway involving both N- and C-hydroxylations can lead to the 
generation of alkyl diazohydroxide (Fig. 3b). The same type of proximate 
carcinogen is formed in the metabolic degradation of nitrosamines derived from 
secondary amines (Fig. 3c). For this reason these environmentally important 
carcinogens have been included in group 3 (Table 3). 
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Fig. 3a-c. Metabolie activation of carcinogens via oxidation of nitrogen or of an alpha carbon to a 
nitrosated amine. a Beta-naphthylamine as an aromatic amine, b 1,2-dirnethylhydrazine; the 
epoxide stands also for the azoxy resonance structures, c dirnethylnitrosamine 
I 
I 
I 
I 
! 
I 
200 W. K. Lutz 
Table 3. Group 3 of IARC 1980 list of carcinogens: aromatic amines, hydrazines, nitrosamines. 
Activation by oxidation of nitrogen or alpha-carbon to nitrogen (9 of 54) 
a) Aromatic amines. 
b) Hydrazines 
c) Nitrosamines 
Numbering according to IARC (1980) 
* Additional carcinogen 
3. 4-Aminobiphenyl 
4. Amitrole 
7./8. Auramine and its manufacture 
10. Benzidine 
39. 2-Naphthylamine 
43. Phenacetin 
45. N-Phenyl-2-naphthylamine 
33. Isoniazid 
* Dirnethylnitrosamine 
Group 4: Halogenated Hydrocarbons 
This is a highly complex dass of carcinogens. Some can be dehydrohalogenated 
to an olefin (Fig. 4a; to a group 2 compound), some are known to undergo 
homolytic deavage of a halogen-carbon bond and thus give rise to radicals able 
to react with critical target molecules or to lead to the generation of even more 
dangerous radicals (Fig. 4b). iri addition to this potential formation of reactive 
intermediat es, most of the halogenated hydrocarbons are well-known inducers of 
drug-metabolizing enzymes so that they have often been attributed, without 
experimental backup though, some type of co-carcinogenic activity. To make the 
situation even more complex, a number of these compounds have been shown to 
stimulate cell diviaion and to act as tumor promoters in two-stage carcinogenicity 
tests ( see Schulte-Hermann 1981). Some carcinogens of this dass may therefore 
act on a variety of levels and it will be most challenging to determine the relative 
importance of the particular activities. However, one should not forget that the 
overall carcinogenic potency is low for this dass of compounds and that many 
aspects may turn out to be species specific. It is therefore not surprising to see 
that the evidence for carcinogenicity in humans of the four members of this dass, 
listed among the 54 (Table 4), has been termed inadequate by IARC 
(1980). 
a) 
b) 
Cll()i rQYCI 
c1-@-7H-@-CI- ~rf~ CCI3 C cv" 'Cl 
(2) 
Fig. 4a, b. Possible steps in the metabolic activation of halogenated hydrocarbons. a DDT 
dehydrohalogenated to an olefin, b homolytic cleavage of carbon tetrachloride to radicals 
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Table 4. Group 4 of IARC 1980 list of carcinogens: aliphatic halogenated compounds ( 4 of 54) 
a) Dehydrohalogenation to olefin (group 2) 
b) Homolytic cleavage of C-Cl bond to radical 
Numbering according to IARC (1980) 
Group 5: Preceding Reactions Required 
22. DDT 
31. Hexachlorocyclohexane 
15. Carbon tetrachloride 
23. Dieldrin (also group 1) 
This group of compounds requires some enzymatic modification of the molecule 
which is either not normally performed in the mammalian cell (nitro reduction or 
beta-glucosidase activity) or which does not center around the atom to become 
reactive (phosphoramide cleavage of a non-reactive mustard to liberate a 
reactive mustard or aromatization of a pyrrolizidine alkaloid to generate 
"benzylic" - CH+- and CHi). These reactions are depicted in Fig. 5 ( a and c, b 
and d, respectively). Only two such examples have been found in the IARC 1980 
list of carcinogens (Table 5, a and b) and two have been added for the sake of 
Fig. 5a-d. Selection of carcinogens 
known to require a preceding reaction 
not normally performed in the target 
cell ( a, nitroreductase; 
c, beta-glucosidase) or not at the atom 
to become electrophilic 
(b, phosphoramide cleavage of 
cyclophosphamide to release a reactive 
mustard; d, aromatization of pyrrolizidine 
alkaloid to generate benzyl analogues) 
" 
a) 
-
b) 
-
1d 
Table 5. Group 5 of IARC 1980 list of carcinogens: preceding reactions required (2 of 54) 
a) Nitroreduction 
b) Phosphoramide cleavage 
c) Glucoside cleavage 
d) Aromatization 
Numbering according to IARC (1980) 
* Additional carcinogens 
17. Chloramphenicol (to aromatic amine) 
21. Cyclophosphamide (to reactive mustard) 
* 
* 
Cycasin ( to group 1) 
Pyrrolizidine alkaloids 
(3a) 
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completeness. Nitroreductase and beta-glucosidase both are activities present in 
microorganisms, and it cannot, therefore, be surprising that the genotoxicity of 
dinitrotoluene is no Ionger observed in germ-free animals (Mirsalis et al. 1982). 
It is also conceivable that the diet can have an indirect influence on the 
carcinogenicity of this type of compound by changing the number and 
composition of the gut microflora. 
Answer to Ouestion 1: Sensitivity for Organic Compound is Very High 
Table 6 shows that it would be possible to identify as much as 72% of the 54 
carcinogens of the IARC list and even 91% if only organic chemieals are 
considered. This sensitivity is even slightly better than with the Ames test if 
applied to this selection of carcinogens, because of the well-documented 
problems of the Am es test with halogenated compounds and hydrazines (Rinkus 
and I:egator 1979). 
Table 6. Carcinogens of IARC 1980 list which could have been detected on the basis of structural 
elements 
Group 1: Chemically reactive 
Group 2: Substituted olefins 
Group 3: Aromatic amines/hydrazines " 
Group 4: Aliphatic halogenated compounds 
Group 5: Nitroaromaries and miscellaneous 
Total 
If only organic carcinogens are taken 
13 
13 
9 
3 new 
1 new 
39 of 54 (72%) 
39 of 43 (91%) 
The compounds of the IARC 1980 list which would not have been detected 
on the basis of structural elements as presented in groups 1-5 are primarily 
inorganic and include derivatives of arsenic (no. 5 of the IARC list), beryllium 
(11), cadmium (14), chromium (20), lead (36), nickel (40 and nickel refining, 
41), as well as asbestos (6) and hematite (29 and its mining, 30). One possible 
mechanism of carcinogenic action might involve an interaction with the DNA 
polymerase system and a resulting decrease of template fidelity but such activity 
is obviously not amenable to an analysis of electrophilicity. Only four organic 
chemical are missed, i.e., iron dextran (32), isopropyl oils and their manufacture 
(34 and 35), oxmetholone ( 42) and reserpine ( 48). The latter two are known to 
interfere with the endocrine system. They could therefore be carinogenic along 
the line of hormones and are detectable in chronic toxicity studies by their 
respective activities. 
Question 2: How Good is the Specificity? 
The questionof specificity deals with the problern of how many from a selection 
of non-carcinogens do not have structural elements placing them into one of 
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Fig. 6. Schematic metabolism of 
benzene, phenol, and toluene 
COOH 
6- Phase II 
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groups 1-5. A simple example shown in Fig. 6 illustrates the main problem. 
Benzene, toluene, and phenol would all have to be termed potential 
carcinogens, if the rules set out above are adopted and they are placed in 
group 2. Only benzene is a detectabJe systemic carcinogen (Dean 1978). This is 
mainly because the metabolism of the other two compounds goes primarily via 
true detoxication reactions, such as the oxidation of the side chain of toluene and 
conjugation reactions with phenol. The oxidation in the ring does occur with 
both but represents only a minor pathway. 
One could think of introducing this type of knowledge into the evaluation 
and to state that alkyl~ed or phenolic aromatic hydrocarbons are less dangerous 
than their parent compounds. This approach would not be of much quantitative 
value because of two main points. 
Firstly, in some instances, such as with benz(a)anthracene derivatives, many 
methylated analogues are much morepotent carcinogens (Oesch 1982), or, the 
conjugation reaction can even be a prerequisite for the formation of the ultimate 
reactive carcinogen, such as with the aromatic amines or with 1,2-dibromo-
ethane, where the reaction with glutathione leads to a reactive brominated sulfur 
mustard. 
Secondly, on a quantitative basis, all the modulations are not taken into 
account which ultimately determine the concentration of reactive metabolite at 
the target and the reactivity with DNA. The competing activation and 
inactivation processes are highly complex and controlled on many possible levels 
some of which are discussed in later presentations. 
It therefore seems that only in vivo studies can possibly give a quantitative 
answer on the level of DNA darnage exerted by reactive metabolites. The 
difference between benzene and toluene for instance becomes very clear when a 
DNA-binding assay is performed in rats. The bindingtoliver DNA was found to 
be at least 40 times higher for benzene (Lutz and Schlatter 1977) if compared 
with toluene (Table 7). 
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Table 7. Covalent binding of [14C]benzene and [p-3H]toluene to rat liver DNA after exposure in a 
closed inhalation system 
Compound 
Dose 
(mg/kg) 
(1 09 dpm/kg) 
Period of exposure (h) 
Formation of tritiated water (% of dose) 
Liver DNA 
In via] (mg) 
Spec. act. ( dpmlmg) 
(CBI units)" 
Benzene 
62 
6.5 
9 
2.3 
42 
1.7 
63 
6.6 
11.5 
2.2 
37 
1.5 
Toluene 
64 
182 
5 
0.6 
2.5 
25 
<0.04 
a Specific activity of DNA normalized by the dose administered and converted to molar units as 
defined in the list of abbreviations 
Answer to Question 2: Bad Specificity 
Therefore, it must be concluded that a large number offalsepositive answers will 
be generated if structure-activity considerations are used as a short-term test for 
carcinogenicity. Only in vivo exp~riments would accurately take account into the 
inactivation reactions which can be responsible for drastic reductions in the 
concentration of reactive metabolites at the target molecule. The specificity will 
therefore be bad, worse than with the Ames test where some inactivation 
processes, albeit distorted, are still taken into account. Because of the ready 
availability of the Ames test as a highly sensitive screening test for the 
production of metq.bolites damaging bacterial DNA, it would not seem that a 
sophisticated decision tree as set forth by Cramer et al. (1978) would be an 
alternative. 
Question 3: What is the Role of React.i.ve Metabolites 
in Over-all Carcinogenicity? 
Table 8 gives an outline of the possible modes of action of chemical carcinogens, 
divided into mutagenic and non-mutagenic events, each group being subdivided 
into possible specific activities. A compound exhibiting any one single activity 
could be found to increase the tumor incidence in a long-term bioassay on 
carcinogenicity if it is accepted that mutational events are to some extent 
unavoidable (Lutz 1982), and that the respective mutations can also form the 
basis for spontaneaus tumor formation. 
The reactive metabolites, discussed here, seem to act primarily by DNA 
binding. In addition, and as mentioned for the group of the halogenated 
hydrocarbons, there is the possibility of radical-induced darnage also in other 
classes of compounds which might act via oxygen radical formation. Other 
papers in this volume will deal more thouroughly with this aspect. Besides these 
.. ' 
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Table 8. List of possible modes of action of chemical carcinogens 
Mutagenicity 
Derived from 
- DNA binding of test compound 
- Indirect DNA darnage 
e.g., via oxygen radicals 
Other mutagenic mechanisms 
Non-mutagenicity 
(modulation of mutational events) 
At the Ievel of 
- Pre-mutagenicity 
more DNA binding, 
more oxygen radicals 
- Co-mutagenicity 
more rapid fixation of DNA darnage 
(stimulation of cell division) 
- Post-mutagenicity 
better expression of critical 
mutation towards tumor growth 
( = promotion ?) 
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two modes of obvious genotoxicity, a number of additional mechanisms on the 
chromatid and chromosome levels will lead to mutations in a broadest 
sense. 
On the non-mutational side, modulations have to be dealt with on many 
levels. Enzyme induction is often referred to as a possible co-carcinogenic 
mechariism of action although all reports seem to show the opposite: a 
"' pretreatment of animals with enzyme inducers of any kind, so far, has always led 
to a reduction in the incidence of tumors induced by a subsequent dose of a 
DNA-binding carcinogen (Wattenberg 1978). 
The step between DNA darnage and mutation is dependent on the repair of 
the critical DNA damage, the mutagenicity of the various adducts, and on the 
rate of DNA synthes~s, i.e., of the rate of cell division. Any influence which 
increases the cell divisionrate reduces the time available for repair and increases 
the probability for a fixation of the darnage in the form of mutation. Hormones 
might therefore be found tobe carcinogenic in an animal bioassay on the basis of 
their stimulatory effect on target cell division. 
Some compounds listed among the 54 IARC carcinogens are known to lead 
to liver growth in rodents, such as hexachlorocyclohexane (HCH) or 
phenobarbital. Both have also been mentioned before because of their critical 
structural elements. It is therefore possible that these compounds act by more 
than one mode. The third question raised here will deal with the quantitative 
importance of a single activity like DNA binding. 
HCH includes a group of isomers of which the gamma-isomer, called 
lindane, has useful pesticidal activities. The alpha-isomer is a moderately strong 
hepatocarcinogen, much stronger than the gamma-isomer for which the 
evidence for carcinogenicity is inconclusive. The tumor induction in mice is 
strongly dependent on the strain used. Both isomers could give rise to reactive 
metabolites via dehydrohalogenation to an olefin and epoxidation. A DNA 
binding assay in mouse liver was performed with oral administration of tritiated 
HCH and isolation of the DNA after 10 h (Sagelsdorff et al. 1983). The results 
support the view that DNA-binding cannot be the decisive mode of tumorigenic 
~,c . . . . . 
206 W. K. Lutz 
activity in that Covalent Binding Indices, CBI (see list of abbreviations for 
definition), of :::::; 0.26 and :::::; 0.18 were determined for the gamma- and the 
alpha-isomer, respectively. The alpha-isomer therefore did not give rise to a 
higher CBI although it is the much morepotent carcinogen. Furthermore, it was 
shown that the CBI of gamma-HCH for mouse liver DNA was :::::; 0.28, :::::; 0.26, 
and:::::; 0.17 in the NMRI, CF1, and B6C3F1 strain, i.e., similar DNA binding 
was found in all strains of mice tested although the CF1 mice are more 
susceptible than the others. In addition, the absolute level of DNA binding 
determined for the alpha-isomer is by a factor · of about three orders of 
magnitude lower than with typical DNA-binding carcinogens of similar 
carcinogenic potency (Lutz 1982). 
HCH isomers therefore seem not to belong tothat population of carcinogens 
where DNA binding is the most important mode of action although DNA 
binding is possible from structure-activity considerations and measurable in 
VIVO. 
In conclusion, the carcinogenicity of a chemical must be considered to be the 
result of the sum of a variety of single contributing factors. The example given 
above with hexachlorocyclohexane is only one of a probably large number of 
cases where the reactive metabolites and the respective DNA binding cannot be 
the main mode of carcinogenic activity. Conversely, this means that the lack of 
structural elements known to become potentially reactive dose not guarantee the 
lack of a carcinogenic potential and it will be important to establish biological 
activities common to representatives of the non-reactive carcmogens. 
Answer to Question 3: Reactive Metabolites and Their DNA-Binding 
are not Always Decisive for a Carcinogenic Activity of a Chemical 
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